News Releases

Month Year

Investor Alerts

Sep 18, 2019

Anika Commences U.S. Commercial Launch of TACTOSET Bone Repair Therapy Under Its New U.S. Hybrid Commercial Model

BEDFORD, Mass.--(BUSINESS WIRE)--Sep. 18, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic medicines company leveraging its proprietary hyaluronic acid ("HA")...
Sep 4, 2019

Anika Therapeutics to Host Analyst and Investor Day on September 18, 2019

BEDFORD, Mass.--(BUSINESS WIRE)--Sep. 4, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary...
Sep 3, 2019

Anika to Participate in the 2019 Morgan Stanley Global Healthcare Conference on September 10, 2019

BEDFORD, Mass.--(BUSINESS WIRE)--Sep. 3, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on...
Aug 13, 2019

Anika Announces Successful Completion of First Human Surgical Procedure with Injectable HA-Based Bone Repair Therapy

Company to Deploy Hybrid Commercial Strategy to Support U.S.Sales and Distribution

BEDFORD, Mass.--(BUSINESS WIRE)--Aug. 13, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on...
Jul 24, 2019

Anika Reports Second Quarter 2019 Financial Results

Delivers Strong Bottom Line Performance with $0.67 Diluted EPS

BEDFORD, Mass.--(BUSINESS WIRE)--Jul. 24, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on...
Jul 11, 2019

Anika to Exhibit its HA-Based Bone Repair Therapy at the 2019 American Orthopaedic Society for Sports Medicine Annual Meeting

BEDFORD, Mass.--(BUSINESS WIRE)--Jul. 11, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics and regenerative medicines company specializing in therapeutics based on...
Jul 10, 2019

Anika to Issue Second-Quarter 2019 Financial Results and Business Highlights on Wednesday, July 24

BEDFORD, Mass.--(BUSINESS WIRE)--Jul. 10, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its second-quarter 2019 financial results after the close...
Jul 8, 2019

Anika Appoints James Loerop as Executive Vice President of Business Development and Strategic Planning

Industry veteran brings extensive experience leading business development groups

BEDFORD, Mass.--(BUSINESS WIRE)--Jul. 8, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on...
Jun 5, 2019

Anika Announces Plans to Showcase HYALOFAST Hyaluronic Acid-Based Cartilage Repair Scaffold at the 2019 International Cartilage Regeneration and Joint Preservation Society (ICRS) Focus Meeting

BEDFORD, Mass.--(BUSINESS WIRE)--Jun. 5, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on...
May 13, 2019

Anika to Showcase Regenerative Medicine and Orthobiologics Portfolio at the 12th Biennial International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine Congress

BEDFORD, Mass.--(BUSINESS WIRE)--May 13, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on...

Show per page